Trial-Based Cost-Utility Analysis of Icotinib versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in China

Open Access

Peer-reviewed

Research Article

Chunxiang Zhang ,

* E-mail: aixiama73@126.com (AM); luckyzcx@126.com (CZ)

Affiliations School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu Province, China, Department of Pharmacy, Nanjing Jiangning Hospital, Nanjing, Jiangsu Province, China
⨯
Hongmei Zhang,

Affiliation Department of Blood Transfusion, Nanjing Jiangning Hospital, Nanjing, Jiangsu Province, China
⨯
Jinning Shi,

Affiliation Department of Blood Transfusion, Nanjing Jiangning Hospital, Nanjing, Jiangsu Province, China
⨯
Dong Wang,

Affiliation Department of Blood Transfusion, Nanjing Jiangning Hospital, Nanjing, Jiangsu Province, China
⨯
Xiuwei Zhang,

Affiliation Department of Respiratory, Nanjing Jiangning Hospital, Nanjing, Jiangsu Province, China
⨯
Jian Yang,

Affiliation Department of Respiratory, Nanjing Jiangning Hospital, Nanjing, Jiangsu Province, China
⨯
Qizhi Zhai,

Affiliation Department of Respiratory, Nanjing Jiangning Hospital, Nanjing, Jiangsu Province, China
⨯
Aixia Ma

* E-mail: aixiama73@126.com (AM); luckyzcx@126.com (CZ)

Affiliation School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu Province, China
⨯

Reader Comments (0)

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Health economics
Is the Subject Area "Health economics" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Markov models
Is the Subject Area "Markov models" applicable to this article?

Thanks for your feedback.
China
Is the Subject Area "China" applicable to this article?

Thanks for your feedback.